Acorah Software Products - Accounts Production 19.3.600 false true true 28 February 2025 1 March 2024 false 1 March 2025 28 February 2026 28 February 2026 14670245 Mr Wadah Malaeb Dloc Biosystems Inc, true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14670245 2025-02-28 14670245 2026-02-28 14670245 2025-03-01 2026-02-28 14670245 frs-core:CurrentFinancialInstruments 2026-02-28 14670245 frs-core:ComputerEquipment 2026-02-28 14670245 frs-core:ComputerEquipment 2025-03-01 2026-02-28 14670245 frs-core:ComputerEquipment 2025-02-28 14670245 frs-core:PlantMachinery 2026-02-28 14670245 frs-core:PlantMachinery 2025-03-01 2026-02-28 14670245 frs-core:PlantMachinery 2025-02-28 14670245 frs-core:ShareCapital 2026-02-28 14670245 frs-core:RetainedEarningsAccumulatedLosses 2026-02-28 14670245 frs-bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 14670245 frs-bus:FilletedAccounts 2025-03-01 2026-02-28 14670245 frs-bus:SmallEntities 2025-03-01 2026-02-28 14670245 frs-bus:AuditExempt-NoAccountantsReport 2025-03-01 2026-02-28 14670245 frs-bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 14670245 1 2025-03-01 2026-02-28 14670245 frs-bus:Director1 2025-03-01 2026-02-28 14670245 frs-core:CurrentFinancialInstruments 1 2026-02-28 14670245 frs-countries:EnglandWales 2025-03-01 2026-02-28 14670245 2024-02-29 14670245 2025-02-28 14670245 2024-03-01 2025-02-28 14670245 frs-core:CurrentFinancialInstruments 2025-02-28 14670245 frs-core:ShareCapital 2025-02-28 14670245 frs-core:RetainedEarningsAccumulatedLosses 2025-02-28 14670245 frs-core:CurrentFinancialInstruments 1 2025-02-28
Registered number: 14670245
DLOC BIOSYSTEMS LTD
Financial Statements
For The Year Ended 28 February 2026
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2—4
Page 1
Balance Sheet
Registered number: 14670245
2026 2025
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 10,133 10,228
10,133 10,228
CURRENT ASSETS
Debtors 5 115,190 150,725
Cash at bank and in hand - 2,771
115,190 153,496
Creditors: Amounts Falling Due Within One Year 6 (175,718 ) (190,676 )
NET CURRENT ASSETS (LIABILITIES) (60,528 ) (37,180 )
TOTAL ASSETS LESS CURRENT LIABILITIES (50,395 ) (26,952 )
NET LIABILITIES (50,395 ) (26,952 )
CAPITAL AND RESERVES
Called up share capital 7 1 1
Profit and Loss Account (50,396 ) (26,953 )
SHAREHOLDERS' FUNDS (50,395) (26,952)
For the year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Wadah Malaeb
Director
21 August 2026
The notes on pages 2 to 4 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
DLOC BIOSYSTEMS LTD is a private company, limited by shares, incorporated in England & Wales, registered number 14670245 . The registered office is Innovation House Innovation Way, Discovery Park, SANDWICH, KENT, CT13 9FF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The financial statements have been prepared on a going-concern basis notwithstanding the company’s net liabilities of £50,395 as at 28 February 2026. DLOC Biosystems Inc., an entity under common control, has confirmed its intention to continue providing business and financial support to enable the company to meet its liabilities as they fall due for a period of at least 12 months from the date of approval of these financial statements. On this basis, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future and therefore continues to adopt the going-concern basis of accounting in preparing these financial statements.
2.3. Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
2.4. Research and Development
Research expenditure is recognised as an expense when incurred. Development expenditure is capitalised only when the applicable recognition criteria are met. No development expenditure was capitalised during the year.
2.5. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 5 years straight line
Computer Equipment 5 years straight line
2.6. Financial Instruments
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
...CONTINUED
Page 2
Page 3
2.6. Financial Instruments - continued
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
2.7. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 5 (2025: 7)
5 7
4. Tangible Assets
Plant & Machinery Computer Equipment Total
£ £ £
Cost
As at 1 March 2025 6,542 4,607 11,149
Additions 641 1,716 2,357
As at 28 February 2026 7,183 6,323 13,506
Depreciation
As at 1 March 2025 230 691 921
Provided during the period 1,373 1,079 2,452
As at 28 February 2026 1,603 1,770 3,373
Net Book Value
As at 28 February 2026 5,580 4,553 10,133
As at 1 March 2025 6,312 3,916 10,228
Page 3
Page 4
5. Debtors
2026 2025
£ £
Due within one year
Prepayments and accrued income 8,304 52,888
VAT recoverable 9,229 12,268
Amounts owed by Company Under Common Control 97,657 85,569
115,190 150,725
6. Creditors: Amounts Falling Due Within One Year
2026 2025
£ £
Trade creditors 91,712 99,874
Bank loans and overdrafts 249 -
Other creditors 78,402 82,913
Taxation and social security 5,355 7,889
175,718 190,676
7. Share Capital
2026 2025
£ £
Allotted, Called up and fully paid 1 1
8. Related Party Transactions
During the year, the company provided research and development services to DLOC Biosystems Inc., an entity under common control. Income recognised from these services amounted to £683,035 (2025: £499,970), and £97,656 was due from DLOC Biosystems Inc. at 28 February 2026 (2025: £85,569).
The company received subcontracted research and development services from DLOC BIO SARL, an entity under common control. The cost of these services amounted to £243,669 (2025: £3,438), and £56,087 was payable to DLOC BIO SARL at 28 February 2026 (2025: £58,244).
The transactions were undertaken under the relevant intercompany arrangements.
9. Ultimate Controlling Party
The ultimate controlling party of the company is Mr Waddah Malaeb, who owns 100% of the company’s issued share capital.
Page 4